Literature DB >> 26412599

New concepts in the therapy of atrial fibrillation.

Giuseppe Cocco1, Paul Jerie.   

Abstract

Atrial fibrillation is a frequent arrhythmia with increasing prevalence. The paper reviews the most important present aspects and paradigms in the treatment of the arrhythmia. The main aim of treatment is directed to improve the quality of life while reducing morbidity and mortality. A large experience derived from epidemiological registers and clinical research, impressive advances in interventional electrophysiological therapies and the introduction of non-vitamin K antagonists had a dramatic impact on the medical approach. Recommended steps to classify and treat atrial fibrillation are presented and discussed.

Entities:  

Keywords:  atrial fibrillation

Mesh:

Substances:

Year:  2015        PMID: 26412599     DOI: 10.5603/CJ.a2015.0053

Source DB:  PubMed          Journal:  Cardiol J        ISSN: 1898-018X            Impact factor:   2.737


  3 in total

1.  The use of anticoagulants in chronic kidney disease: Common point of view of cardiologists and nephrologists.

Authors:  Justyna Domienik-Karłowicz; Olga Tronina; Wojciech Lisik; Magdalena Durlik; Piotr Pruszczyk
Journal:  Cardiol J       Date:  2019-03-26       Impact factor: 2.737

Review 2.  microRNA in Cardiovascular Aging and Age-Related Cardiovascular Diseases.

Authors:  Claudio de Lucia; Klara Komici; Giulia Borghetti; Grazia Daniela Femminella; Leonardo Bencivenga; Alessandro Cannavo; Graziamaria Corbi; Nicola Ferrara; Steven R Houser; Walter J Koch; Giuseppe Rengo
Journal:  Front Med (Lausanne)       Date:  2017-06-12

3.  Clinical characteristics and thromboembolic risk of atrial fibrillation patients with and without congestive heart failure. Results from the CRATF study.

Authors:  Paweł Balsam; Monika Gawałko; Michał Peller; Agata Tymińska; Krzysztof Ozierański; Martyna Zaleska; Katarzyna Żukowska; Katarzyna Szepietowska; Kacper Maciejewski; Marcin Grabowski; Mariusz Borkowski; Łukasz Kołtowski; Anna Praska-Oginska; Inna Zaboyska; Grzegorz Opolski; Janusz Bednarski
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.